Lung cancer | Benign disease | |||
---|---|---|---|---|
(185) | (55) | |||
n | % | n | % | |
Age (years) | ||||
Mean ± SEM | 66.8 ± 9.2 | 65.0 ± 10.8 | ||
Range | 32–85 | 19–85 | ||
Gender | ||||
Female (%) | 61 | 33.00% | 17 | 29.10% |
smorking | 2 | 3.30% | 0 | 0% |
Male (%) | 124 | 67.00% | 38 | 70.90% |
smorking | 52 | 41.90% | 19 | 50% |
Histology subtype | ||||
LUAC | 104 | 56.20% | - | |
LUSC | 53 | 28.60% | - | |
SCLC | 23 | 12.40% | - | |
Metastatic Cancer | 5 | 2.70% | - | |
Infalmmatory Pseudotumors | 37 | 67.30% | ||
Pulmonary Tuberculosis | 6 | 10.90% | ||
Others benign disease | 12 | 21.80% | ||
Stages of Lung cancer | ||||
I | 28 | 15.10% | - | |
II | 20 | 10.80% | - | |
III | 40 | 21.60% | - | |
IV | 97 | 52.40% | - | |
Largest diameter of pulmonary nodule | ||||
0 ~ 10 mm | 10 | 5.40% | - | |
11 ~ 50 mm | 124 | 67.00% | - | |
51 ~ 100 mm | 29 | 15.70% | - | |
101 ~ 300 mm | 12 | 6.50% | - | |
Unknown | 10 | 5.40% | - |